Currently, treatment for patients with T2D includes reducing liver glucose metabolism (Wu et al., 2005), improving endogenous insulin secretion (Kaneko et al., 2019), limiting kidney glucose re-absorption (Vallon and Thomson, 2017), and lifestyle modification (diet and exercise) (Kolb and Martin, 2017). Here, INS is linked to type 2 diabetes mellitus.